Outcome of patients with metastatic cancer or haematological malignancy in intensive care
© Meynaar et al; licensee BioMed Central Ltd. 2009
Published: 13 March 2009
We studied our ICU database to estimate the effect of metastatic cancer and haematological malignancy on hospital mortality after intensive treatment.
The Reinier de Graaf Hospital is a 500-bed nonacademic teaching hospital with a 30-bed dedicated medical oncology ward supervised by a team of medical oncologists and a 10-bed mixed intensivist-led ICU. Data on all patients admitted to the ICU including illness severity scores, the presence of metastatic cancer or haematological malignancy and hospital mortality are prospectively collected in the ICU database. We studied the hospital mortality of all consecutive patients in the database admitted from 2004 until 2007 with respect to the presence or absence of metastatic cancer or haematological malignancy.
Mean APACHE II score
APACHE II expected mortality
Hospital mortality is higher in patients with metastatic cancer or haematological malignancy than in other patients, even after correction for age, APACHE II expected mortality, admission type, sepsis and mechanical ventilation.
This article is published under license to BioMed Central Ltd.